Skip to main content

Author: Leigh MacMillan

Commensal gut bacterium protects from severe intestinal infection

Nov. 21, 2023— The commensal bacterium Turicibacter sanguinis could be used to protect against severe intestinal infections, Vanderbilt researchers discovered.

Read more


Novel C. diff structures are required for infection, offer new therapeutic targets

Nov. 15, 2023—Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs.

Read more


Study discovers role for gut bacteria in host-pathogen competition for nutrients

Oct. 27, 2023—Vanderbilt research shows that commensal gut microbes impact the host-pathogen competition for iron and has implications for therapeutic strategies aimed at preventing pathogens from acquiring essential nutrients.

Read more


Vanderbilt-led team receives 2023 Endeavor Award from The Mark Foundation for Cancer Research

Oct. 24, 2023—A multidisciplinary team of investigators has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research to support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection,

Read more


Researchers discover molecular signature for aggressive thyroid cancer

Sep. 25, 2023—A Vanderbilt study found that a molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients.

Read more


Bone metabolism changes with aging

Sep. 14, 2023—Vanderbilt researchers have detailed how aging alters the metabolism of bone-forming cells, which could contribute to age-related osteoporosis.

Read more


Discovery lecture features computational cancer biologist Pe’er

Sep. 12, 2023—Dana Pe’er, PhD, a pioneer in using machine learning approaches to explore cell identities and interactions, will deliver the next Discovery Lecture on Thursday, Sept. 21.

Read more


MicroRNAs in immune cells help protect against metabolic defects in obesity: study

Sep. 5, 2023—Vanderbilt researchers have demonstrated that a cluster of microRNAs — small pieces of RNA that regulate gene expression — work in a type of immune cells called macrophages to help protect against metabolic defects in obesity.

Read more


Study finds hallmarks of T cell exhaustion within hours of tumor exposure

Aug. 3, 2023—Vanderbilt researchers found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional.

Read more


Personalizing treatment for sinus syndrome

Aug. 2, 2023—Understanding the inflammatory characteristics of subtypes of chronic rhinosinusitis with polyps should assist with selection of effective therapies, Vanderbilt researchers report.

Read more


Signaling pathways in liposarcomas

Jul. 25, 2023—A broad bioinformatics approach revealed that Hedgehog signaling is upregulated in dedifferentiated liposarcoma, suggesting this pathway may be an early indicator of poor prognosis and a potential therapeutic target.

Read more


Female health care workers more likely to leave profession during pandemic: HERO registry study

Jul. 13, 2023—Vanderbilt research finds that female health care workers were more likely to leave or intend to leave the profession compared to male health care workers during the COVID-19 pandemic.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more